Cardiac Science (CSCX) Reports Large Q3 Loss; Issues Mixed Guidance for Q4

November 9, 2009 4:35 PM EST Send to a Friend
Cardiac Science (NASDAQ: CSCX) reports a Q3 loss of $2.85 vs. the analyst estimate of ($0.12) - may not be ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login